• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The incidence and characteristics of VTE within 100 days of CAR T-cell therapy.

作者信息

Gaffney Kelly J, McGann Mary, Davis James A, Edwards Kathy H, Hashmi Hamza

机构信息

Medical University of South Carolina, Charleston, SC, USA.

出版信息

Ann Hematol. 2023 Mar;102(3):683-685. doi: 10.1007/s00277-023-05104-w. Epub 2023 Jan 19.

DOI:10.1007/s00277-023-05104-w
PMID:36658372
Abstract
摘要

相似文献

1
The incidence and characteristics of VTE within 100 days of CAR T-cell therapy.嵌合抗原受体T细胞疗法（CAR T-cell therapy）100天内静脉血栓栓塞症（VTE）的发病率及特征
Ann Hematol. 2023 Mar;102(3):683-685. doi: 10.1007/s00277-023-05104-w. Epub 2023 Jan 19.
2
Venous thromboembolism in cancer and cancer immunotherapy.癌症与癌症免疫治疗中的静脉血栓栓塞症
Crit Rev Oncol Hematol. 2022 Oct;178:103782. doi: 10.1016/j.critrevonc.2022.103782. Epub 2022 Aug 10.
3
Familial transmission of venous thromboembolism: a cohort study of 80 214 Swedish adoptees linked to their biological and adoptive parents.静脉血栓栓塞症的家族传播：一项对80214名瑞典领养者与其亲生父母和养父母进行关联研究的队列研究。
Circ Cardiovasc Genet. 2014 Jun;7(3):296-303. doi: 10.1161/CIRCGENETICS.113.000341. Epub 2014 May 2.
4
Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience.接受 axi-cel 治疗的复发/难治性 B 细胞淋巴瘤的血栓形成发生率：梅奥诊所经验。
Leuk Lymphoma. 2022 Jun;63(6):1363-1368. doi: 10.1080/10428194.2022.2030475. Epub 2022 Feb 3.
5
Venous thromboembolic events in T-cell lymphoma patients: Incidence, risk factors and clinical features.T 细胞淋巴瘤患者的静脉血栓栓塞事件：发生率、风险因素和临床特征。
Leuk Res. 2021 Apr;103:106537. doi: 10.1016/j.leukres.2021.106537. Epub 2021 Feb 15.
6
Incidence and risk factors for symptomatic venous thromboembolism following cholecystectomy.胆囊切除术后有症状静脉血栓栓塞的发生率及危险因素。
Langenbecks Arch Surg. 2015 May;400(4):463-9. doi: 10.1007/s00423-015-1284-0. Epub 2015 Feb 15.
7
Prevalence of venous thromboembolism after lung surgery in China: a single-centre, prospective cohort study involving patients undergoing lung resections without perioperative venous thromboembolism prophylaxis†.中国肺手术后静脉血栓栓塞症的患病率：一项涉及未行围手术期静脉血栓栓塞症预防的肺切除术患者的单中心前瞻性队列研究†。
Eur J Cardiothorac Surg. 2019 Mar 1;55(3):455-460. doi: 10.1093/ejcts/ezy323.
8
Incidence, determinants and the transient impact of cancer treatments on venous thromboembolism risk among lymphoma patients in Denmark.丹麦淋巴瘤患者癌症治疗后静脉血栓栓塞风险的发生率、决定因素和短暂影响。
Thromb Res. 2015 Nov;136(5):917-23. doi: 10.1016/j.thromres.2015.09.001. Epub 2015 Sep 5.
9
Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer.癌症患者接受抗肿瘤治疗与静脉血栓栓塞症的相关性存在差异。
Thromb Haemost. 2020 May;120(5):847-856. doi: 10.1055/s-0040-1709527. Epub 2020 May 5.
10
Incidence and risk factors associated with 30-day post-operative venous thromboembolism: A NSQIP-pediatric analysis.30 天术后静脉血栓栓塞的发生率和相关风险因素：NSQIP-儿科分析。
J Pediatr Urol. 2018 Aug;14(4):335.e1-335.e6. doi: 10.1016/j.jpurol.2018.04.009. Epub 2018 May 8.

本文引用的文献

1
Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells.嵌合抗原受体 T 细胞过继免疫治疗后神经毒性中的血管内皮细胞激活和血脑屏障破坏。
Cancer Discov. 2017 Dec;7(12):1404-1419. doi: 10.1158/2159-8290.CD-17-0698. Epub 2017 Oct 12.
2
[Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study].[血小板生成素受体激动剂治疗免疫性血小板减少症期间的血栓形成。一项法国多中心观察性研究]
Rev Med Interne. 2017 Mar;38(3):167-175. doi: 10.1016/j.revmed.2016.09.016. Epub 2016 Oct 25.